These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16642690)

  • 1. 6.4 million at risk: protecting the poorest Americans during the Medicare drug transition.
    Medicare Rights Center
    Care Manag J; 2005; 6(3):151-8. PubMed ID: 16642690
    [No Abstract]   [Full Text] [Related]  

  • 2. The implications of the Medicare Modernization Act for dual eligibles.
    Deshpande M
    Am J Geriatr Cardiol; 2005; 14(6):298-300. PubMed ID: 16276126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Playing the lottery: HCBS lawsuits and other Medicaid litigation on behalf of the developmentally disabled.
    Feltz MK
    Health Matrix Clevel; 2002; 12(1):181-238. PubMed ID: 12013699
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives. Medicare overhaul: it's not just about drugs.
    Med Health; 2003 Jul; 57(26):7-8. PubMed ID: 12898810
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare and Medicaid programs; limits on payments for drugs--HCFA. Final rule.
    Fed Regist; 1987 Jul; 52(147):28648-58. PubMed ID: 10301766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare part D--what doctors need to know.
    Stephenson L
    Iowa Med; 2005; 95(6):24-5. PubMed ID: 16425707
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare and Medicaid programs, less than effective drugs. Health Care Financing Administration. Notice of legislation affecting implementation and enforcement of interim final rule.
    Fed Regist; 1982 Jan; 47(8):1386. PubMed ID: 10298360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The devil is in the D tales. While politicians squabble, physicians and pharmacists are forced to advise seniors on Part D despite being unprepared.
    Lubell J; DoBias M
    Mod Healthc; 2006 May; 36(20):6-7, 16, 1. PubMed ID: 16752856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals.
    Schweitzer SO; Shiota SR
    Annu Rev Public Health; 1992; 13():399-410. PubMed ID: 1599596
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicaid program; state allotments for payment of Medicare Part B premiums for qualifying individuals: federal fiscal year 1998--HCFA. Notice with comment period.
    Fed Regist; 1998 Jan; 63(16):3752-6. PubMed ID: 10177735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What does the Medicare prescription drug legislation mean for the American cardiologist?
    Schwartz JB; Redberg RF
    Am J Geriatr Cardiol; 2005; 14(6):317-24. PubMed ID: 16276130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between Medicare and Medicaid home care in Connecticut: responses to the 1997 BBA.
    Liu K; Long SK; Kapustka H
    Home Health Care Serv Q; 2001; 20(3):75-88. PubMed ID: 12018687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The most important health care legislation of the millennium (so far): the Medicare Modernization Act.
    Jost TS
    Yale J Health Policy Law Ethics; 2005; 5(1):437-49. PubMed ID: 15742587
    [No Abstract]   [Full Text] [Related]  

  • 16. Coverage changes are coming: get the facts now.
    Biel-Cunningham S
    Surviv News (Atlanta Ga); 2005; 16(3):1, 8, 12. PubMed ID: 16106549
    [No Abstract]   [Full Text] [Related]  

  • 17. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 10 initiatives may ensure uninterrupted drug coverage for dual eligibles.
    Med Health; 2005 Dec; 59(45):2. PubMed ID: 16372742
    [No Abstract]   [Full Text] [Related]  

  • 20. McClellan says CMS will protect duals ... but others express doubts.
    Med Health; 2005 Mar; 59(9):3-4. PubMed ID: 15912644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.